In this issue:
Gene therapy to treat sickle cell disease
Concizumab prophylaxis reduces bleeding rates for patients with haemophilia
Survival with axicabtagene ciloleucel in large B-cell lymphoma
Detailed safety profile of acalabrutinib vs. ibrutinib in previously treated CLL
Mezigdomide plus dexamethasone in relapsed and refractory MM
Improved outcomes with twelve months of anticoagulation
Misdiagnosis of MDS common, may lead to harmful consequences
Luspatercept-aamt approved for anaemia in adults with lower-risk MDS in the U.S.
FDA places partial hold on studies of magrolimab for AML
Blood group A enhances SARS-CoV-2 infection
Higher abatacept exposure after transplant linked to reduced AGVHD risk
BMI impact on toxicities and survival in youth treated with DFCI Consortium ALL regimens
Depression and anxiety in people with haemophilia A and B
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)